Atlas Trials

Stage II-IVB Operable HNSCC Oral Cavity

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Stage II-IVB Operable HNSCC Oral Cavity

RecordFirmDate
Window of Opportunity Trial of Durvalumab (MEDI4736) or Durvalumab/Tremelimumab as Neoadjuvant Chemotherapy to Identify Immune Dynamics in Surgically Resectable Head and Neck Cancer Patients. (NCT03737968)Yonsei University2019-01-02

Track Stage II-IVB Operable HNSCC Oral Cavity automatically

Every clearance here is in the API, with alerts when new ones post.